Engineering model-based systems to monitor and steer subclonal dynamics
基于工程模型的系统来监测和引导亚克隆动态
基本信息
- 批准号:10633383
- 负责人:
- 金额:$ 23.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AdoptedBackBehaviorBiologicalBiological AssayBiological MarkersBiopsyCancer BiologyCancer cell lineCarrying CapacitiesCell CountCell Culture TechniquesCell LineCell LineageCell divisionCellsClinicalClinical TrialsCollaborationsComplexComputer AnalysisComputer Vision SystemsComputer softwareCrystallizationDNADataData CollectionDatabasesDrug ScreeningEarly DiagnosisEngineeringEnvironmentEquipmentEvolutionExhibitsExperimental DesignsFailureFoundationsFutureGenerationsGeneticGenetic TranscriptionGenomeGenomic InstabilityGenotypeGrowthHabitsHarvestHealthHeterogeneityImageIn VitroIndividualJavaLaboratory ResearchLawsLinkMalignant NeoplasmsMathematicsMeasurementMethodologyModelingMonitorMorphologyMycoplasmaNatureNutrientOncologyPathway interactionsPeriodicalsPharmaceutical PreparationsPhasePhenotypePopulationPrimary NeoplasmProteomeProtocols documentationPublishingReagentReproducibilityResearch PersonnelResolutionScientistSilicon DioxideSystemTestingTimecancer heterogeneitycarcinogenesiscontrast imagingcostdriver mutationenvironmental adaptationenvironmental changeexperimental analysisexperimental studyfitnessflexibilitygenetic pedigreehigh throughput screeningin vivolive cell imagingmalignant stomach neoplasmmathematical modelmultiple omicspre-clinicalprototyperesponsesingle cell sequencingsingle-cell RNA sequencingspecific biomarkerssuccesstemporal measurementtranscriptometranscriptome sequencingtumor
项目摘要
ABSTRACT
Primary tumors as well as cancer cell lines have been shown to exhibit extensive genetic and transcriptional
heterogeneity, with multiple subclones co-existing in the same cancer population.1 Even after decades of in-vitro
growth, established cell cultures continue to evolve.2 The heterogeneity of cancer cell lines over space and time
crystallizes into three unmet needs: i) cell culture protocols that offer a high temporal resolution on in-vitro growth
dynamics; ii) close monitoring of the temporal separation between genotypic and phenotypic measurements and
iii) reconciling the cost-prohibitive nature of repeated high-throughput multi-omic measurements with ceaseless
changes in subclonal composition. To fill these needs, we propose to engineer how in-vitro and in-silica experiments
interact into a software solution called CLONEID. An SOL database in the backend, a Java core and an
R user interface will come together to form two modules: One will record the pedigree of lineages grown in a
lab and use computer vision to monitor phenotypic changes, such as variable growth rates. The second module
will link subclonal multi-omics profiles from different high throughput assays to each other and to the phenotypes
from the first module. In aim 1 we will develop the first module and use it to demonstrate feasibility of monitoring
phenotypic transitions of cell lines with CLONE ID at high temporal resolution, without any specialized equipment.
Aim 2 will use this data in conjunction with existing single cell sequencing of the same cell lines to develop and
test the second module and use it to identify subclone-specific biomarkers of growth. Together these aims will
pave the way to more complex mathematical models of carcinogenesis, that do not have to rely on the simplifying
assumption that individual driver mutations have equal fitness effects and that individual subclones have a fixed
growth rate. In the future, the framework developed here will serve as foundation to deploy computer vision for
early detection of morphological changes, including adaptation from in-vivo to in-vitro growth and mycoplasma
contamination.
抽象的
原发性肿瘤以及癌细胞系已被证明表现出广泛的遗传和转录
异质性,多个亚克隆共存于同一癌症群体中。1 即使经过数十年的体外研究
生长,已建立的细胞培养物继续进化。2 癌细胞系随空间和时间的异质性
具体化为三个未满足的需求:i) 为体外生长提供高时间分辨率的细胞培养方案
动力学; ii) 密切监测基因型和表型测量之间的时间间隔
iii) 协调重复高通量多组学测量的成本高昂性质与不断的
亚克隆组成的变化。为了满足这些需求,我们建议设计如何进行体外和硅内实验
与名为 CLONEID 的软件解决方案进行交互。后端有一个 SOL 数据库、一个 Java 核心和一个
R 用户界面将组合在一起形成两个模块:一个模块将记录在一个环境中生长的谱系谱系。
实验室并使用计算机视觉来监测表型变化,例如可变增长率。第二模块
将来自不同高通量检测的亚克隆多组学概况相互关联并与表型关联
从第一个模块开始。在目标 1 中,我们将开发第一个模块并用它来演示监控的可行性
无需任何专门设备,即可在高时间分辨率下使用 CLONE ID 进行细胞系的表型转变。
目标 2 将使用这些数据与相同细胞系的现有单细胞测序相结合来开发和
测试第二个模块并用它来识别亚克隆特异性生长生物标志物。这些目标共同将
为更复杂的致癌数学模型铺平道路,该模型不必依赖于简化
假设个体驱动突变具有相同的适应度效应并且个体亚克隆具有固定的适应度效应
增长率。将来,这里开发的框架将作为部署计算机视觉的基础
早期检测形态变化,包括从体内到体外生长和支原体的适应
污染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Noemi Andor其他文献
Noemi Andor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Noemi Andor', 18)}}的其他基金
Characterizing cytotoxic therapy induced shifts in the cost-to-benefit ratio of high ploidy
细胞毒疗法引起高倍性成本效益比变化的特征
- 批准号:
10688196 - 财政年份:2022
- 资助金额:
$ 23.63万 - 项目类别:
Characterizing cytotoxic therapy induced shifts in the cost-to-benefit ratio of high ploidy
细胞毒疗法引起高倍性成本效益比变化的特征
- 批准号:
10521654 - 财政年份:2022
- 资助金额:
$ 23.63万 - 项目类别:
A framework to integrate live-cell imaging with single-cell sequencing and learn how cells adapt to new environments
将活细胞成像与单细胞测序相结合并了解细胞如何适应新环境的框架
- 批准号:
10337650 - 财政年份:2021
- 资助金额:
$ 23.63万 - 项目类别:
A framework to integrate live-cell imaging with single-cell sequencing and learn how cells adapt to new environments
将活细胞成像与单细胞测序相结合并了解细胞如何适应新环境的框架
- 批准号:
10530677 - 财政年份:2021
- 资助金额:
$ 23.63万 - 项目类别:
A clone's genomic stability as biomarker of its DNA-damage resilience
克隆的基因组稳定性作为其 DNA 损伤恢复能力的生物标志物
- 批准号:
10015210 - 财政年份:2017
- 资助金额:
$ 23.63万 - 项目类别:
A clone's genomic stability as biomarker of its DNA-damage resilience
克隆的基因组稳定性作为其 DNA 损伤恢复能力的生物标志物
- 批准号:
10224800 - 财政年份:2017
- 资助金额:
$ 23.63万 - 项目类别:
相似国自然基金
基于裂隙黄土斜坡模型试验的渐进后退式滑坡成灾机理研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
嵌入后退式分离的复杂流动干扰与分离动力学研究
- 批准号:U21B2054
- 批准年份:2021
- 资助金额:260 万元
- 项目类别:联合基金项目
滑模与适定运动统一的稳定条件及基于值函数的受约束切换系统控制研究
- 批准号:61773006
- 批准年份:2017
- 资助金额:51.0 万元
- 项目类别:面上项目
干热河谷冲沟沟头后退的水力、重力协同作用机制
- 批准号:41571277
- 批准年份:2015
- 资助金额:74.0 万元
- 项目类别:面上项目
多层柱状波导中后退波的传播特性及其应用
- 批准号:11474303
- 批准年份:2014
- 资助金额:90.0 万元
- 项目类别:面上项目
相似海外基金
Informing alcohol policy: The impact of evidence-based alcohol warnings on consumption
告知酒精政策:基于证据的酒精警告对消费的影响
- 批准号:
10565120 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Patterns and neurocognitive consequences of opioid-alcohol polysubstance use
阿片类酒精多物质使用的模式和神经认知后果
- 批准号:
10659347 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Using wastewater surveillance data to study SARS-CoV-2 dynamics and predict COVID-19 outcomes
利用废水监测数据研究 SARS-CoV-2 动态并预测 COVID-19 结果
- 批准号:
10645617 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis
将 p53 动态映射到重编程和肿瘤发生中的细胞命运结果
- 批准号:
10744532 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别: